Last updated on November 2017

Crohn's Disease


Brief description of study

Crohn's Disease

Detailed Study Description

If you are living with Crohn’s, our clinical research study may be for you.

Our team of medical professionals is evaluating an oral investigational drug called filgotinib to see if it reduces the signs and symptoms of Crohn’s disease by lowering the immune response that causes inflammation in the digestive system.

Clinical Study Identifier: TX3396

Contact Investigators or Research Sites near you

Start Over

ClinSearch, LLC

ClinSearch, LLC
Chattanooga, TN USA

Wake Research Associates

Wake Research Associates
Raleigh, NC USA

Carolina's GI Research

Carolina's GI Research
Raleigh, NC USA

ClinSearch

ClinSearch
Chattanooga, TN USA

Arais Quinones

Advanced Pharma - Miami
Miami, FL USA

ClinSearch

ClinSearch
Chattanooga, TN USA

Wake Research Associates

Wake Research Associates
Raleigh, NC USA

Wake Research Associates

Wake Research Associates
Raleigh, NC USA

Global Medical Research

Global Medical Research
DeSoto, TX USA

Carolina's GI Research

Carolina's GI Research
Raleigh, NC USA

Wake Research Associates

Wake Research Associates
Raleigh, NC USA

Carolina's GI

Carolina's GI
Raleigh, NC USA

Wake Research Associates

Wake Research Associates
Raleigh, NC USA